Arcaini, L
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Jul 2008
- 1331-1335 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
ISSN: 1569-8041
Standard No.: 10.1093/annonc/mdn044 doi
Subjects--Topical Terms: Adult Anthracyclines--administration & dosage Antibodies, Monoclonal--administration & dosage Antibodies, Monoclonal, Murine-Derived Antigens, CD20--metabolism Antigens, CD34--analysis Antineoplastic Combined Chemotherapy Protocols--administration & dosage Bleomycin--administration & dosage Bone Marrow Purging--methods Combined Modality Therapy Cyclophosphamide--administration & dosage Cytarabine--administration & dosage Disease Progression Disease-Free Survival Doxorubicin--administration & dosage Drug Administration Schedule Etoposide--administration & dosage Female Follow-Up Studies Genes, bcl-2 Granulocyte Colony-Stimulating Factor--administration & dosage Hematopoietic Stem Cell Mobilization Humans Immunologic Factors--administration & dosage Immunosuppressive Agents--administration & dosage Kaplan-Meier Estimate Lymphoma, Follicular--drug therapy Male Middle Aged Multivariate Analysis Peripheral Blood Stem Cell Transplantation Recurrence Remission Induction Rituximab Time Factors Transplantation, Autologous Treatment Outcome Vincristine--administration & dosage